ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Cancer
Ovarian Cancer
Colorectal Cancer
Endometrial Cancer

Breast Cancer trials near San Antonio, TX, USA:

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (Dauntless-1)

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Active, not recruiting
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

San Antonio, Texas, United States of America and 9 other locations

The purpose of this study is to find out the maximum tolerated dose (MTD) and/or recommended dose(s) for expansion (RDEs) of JNJ-101684362 (HLD-0117)...

Enrolling
Metastatic Breast Cancer
Drug: JNJ-101684362 (HLD-0117)

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

San Antonio, Texas, United States of America and 6 other locations

growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...

Active, not recruiting
Metastatic Breast Cancer
Drug: Elacestrant

Phase 2

Stemline Therapeutics
Stemline Therapeutics

San Antonio, Texas, United States and 22 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

San Antonio, Texas, United States and 78 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Active, not recruiting
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

San Antonio, Texas, United States and 32 other locations

of sapanisertib and serabelisib (PIKTOR) with fulvestrant and/or other anticancer therapies in participants with HR+/HER2- advanced/metastatic breast...

Enrolling
HR+ HER2- Breast Cancer
Drug: Sapanisertib
Drug: Serabelisib

Phase 1, Phase 2

Faeth Therapeutics

San Antonio, Texas, United States and 6 other locations

with NECTIN4-amplified recurrent, unresectable, or metastatic breast cancer who have received prior therapy (see inclusion criteria...

Active, not recruiting
Breast Cancer
Drug: Zelenectide pevedotin (BT8009)

Phase 2

BicycleTx

San Antonio, Texas, United States and 17 other locations

growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals of this study are to:* Learn how well...

Enrolling
Breast Cancer
Drug: Tucatinib
Drug: Doxil

Phase 2

SCRI Development Innovations

San Antonio, Texas, United States and 7 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Active, not recruiting
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States of America and 57 other locations

effective, when combined with chemotherapy, in treating people who has Human Epidermal Growth Factor Receptor 2 (HER2)-positive, early-stage breast...

Enrolling
Breast Cancer
HER2-positive Breast Cancer
Drug: Zanidatamab
Drug: Carboplatin

Phase 2

Jazz Pharmaceuticals
Jazz Pharmaceuticals

San Antonio, Texas, United States and 43 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems